INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00398

Real-time fusion of echocardiography and fluoroscopy allowing successful implantation of a WATCHMAN device without contrast injection

Adel Aminian1*, MD; Mathieu Lempereur2, MD; Mohamed Ben Yedder1, MD; Philippe Dubois1, MD

An 84-year-old man with paroxysmal atrial fibrillation (AF) was scheduled for percutaneous left atrial appendage (LAA) closure. The patient had a high thromboembolic risk based on a CHA2DS2-VASc score of 5 (previous stroke, age >75 years and hypertension) and a prior history of ulcerative colitis with recurrent episodes of major gastrointestinal bleeding under oral anticoagulant therapy. Due to the presence of severe chronic kidney disease (estimated glomerular filtration rate [eGFR] 28 ml/min/1.73 m2), an attempt was made to perform the procedure without contrast injection using the EchoNavigator system (Philips Healthcare, Best, the Netherlands), which allows real-time fusion of 3D transoesophageal echocardiography (TEE) and fluoroscopic images1. Following transseptal puncture, adequate LA filling pressure (14 mmHg) was confirmed and procedural 3D TEE measurements showed a maximal and mean diameter of the landing zone of 25.3 mm and 23.5 mm, respectively. It was decided to implant a 27 mm WATCHMAN™ device (Boston Scientific, Marlborough, MA, USA). The WATCHMAN access sheath was advanced over a 5 Fr pigtail catheter into the LAA cavity. Thanks to the projection of TEE images on the fluoroscopic screen (“fused image”), we could precisely position the 27 mm marker of the access sheath at the level of the landing zone without contrast injection (Panel A, black dotted line). The WATCHMAN device was then released by careful retraction of the access sheath and the correct final position was confirmed by both standard TEE and fused images, without peri-device leak (Panel B, Panel C, Moving image 1). The total procedure duration was 45 minutes.

Prevalence of chronic kidney disease is high in patients undergoing LAA occlusion, approaching 40%2. This case illustrates a potential role of fusing echocardiography and fluoroscopy images during LAA closure with the WATCHMAN device in patients with advanced renal failure in whom contrast injection may be contraindicated. Since the EchoNavigator system relies on optimal 3D-TEE visualisation of the LAA, difficult image acquisition or poor visualisation of the LAA distal lobes during sheath placement may represent a potential technical limitation of this approach.

Conflict of interest statement

A. Aminian is consultant and proctor for Boston Scientific. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. TEE and X-ray fusion during WATCHMAN implantation.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. TEE and X-ray fusion during WATCHMAN implantation.

Volume 14 Number 2
Jun 20, 2018
Volume 14 Number 2
View full issue


Key metrics

On the same subject

IMAGE IN CARDIOLOGY

10.4244/EIJV12I2A44 Jun 10, 2016
The plug for the appendage
Buellesfeld L et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00624 Jun 3, 2022
Percutaneous left atrial appendage closure in a surgically ligated left atrial appendage
Wong I et al
free

Image – Interventional flashlight

10.4244/EIJ-D-18-01064 Apr 16, 2019
Management of incomplete surgical left atrial appendage exclusion
Alkhouli M and Raybuck B
free

EXPERT REVIEW

10.4244/EIJ-D-17-00469 Nov 20, 2017
Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications
Raphael CE et al
free

10.4244/EIJV12SXA10 May 16, 2016
Left atrial appendage closure: patient, device and post-procedure drug selection
Tzikas A and Bergmann M
free

10.4244/EIJV11I14A307 Apr 8, 2016
Percutaneous left atrial appendage occlusion in 2016
Tzikas A et al
free

Clinical research

10.4244/EIJ-D-21-00286 Dec 17, 2021
Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative study
Piayda K et al
free
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved